Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $358,656 - $531,316
1,757 Added 61.8%
4,600 $984,000
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $180,901 - $256,373
708 Added 33.16%
2,843 $807,000
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $750,196 - $957,931
2,135 New
2,135 $804,000
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $3.43 Million - $4.34 Million
-11,670 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $2.63 Million - $3.15 Million
10,532 Added 925.48%
11,670 $3.38 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $741,924 - $844,256
-3,342 Reduced 74.6%
1,138 $284,000
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $20,189 - $26,041
115 Added 2.63%
4,480 $1.02 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $248,494 - $396,704
2,091 Added 91.95%
4,365 $761,000
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $1.38 Million - $2.48 Million
-13,909 Reduced 85.95%
2,274 $287,000
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $1.81 Million - $2.19 Million
14,326 Added 771.46%
16,183 $2.47 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $232,254 - $266,795
1,857 New
1,857 $246,000
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $1.72 Million - $2.08 Million
-13,969 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $1.14 Million - $1.59 Million
10,850 Added 347.87%
13,969 $2.03 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $460,924 - $601,890
-4,386 Reduced 58.44%
3,119 $353,000
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $841,385 - $1.01 Million
7,505 New
7,505 $1.01 Million
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $411,763 - $484,169
-4,100 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $396,552 - $447,966
4,100
4,100 $443,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.